Louise Thoma, PhD, DPT
University of North Carolina
Chapel Hill, North Carolina, United States
Disclosure information not submitted.
Matthew Bunyard, MD, RhMSUS
Cleveland Clinic
Moreland Hills, Ohio, United States
Disclosure information not submitted.
This interactive session, co-moderated by a patient partner and an academic researcher, will provide a comprehensive overview of cognitive dysfunction experienced by people with rheumatic disease, with a focus on rheumatoid arthritis, systemic sclerosis, and fibromyalgia. Attendees will be introduced to fundamental dimensions of cognitive functioning (e.g., memory, attention, executive function, and information processing speed) and epidemiological and qualitative data highlighting the prevalence and impact of cognitive dysfunction in people with rheumatic diseases. The session will also describe and present data on underlying multifaceted mechanisms, such as brain functional alterations, inflammation, pain, fatigue, and mental health factors. A critical focus will be on practical strategies for managing cognitive dysfunction, including cognitive rehabilitation, lifestyle modifications, compensatory strategies and psychological support. Additionally, ongoing and future research directions aimed at developing innovative therapies will be discussed. The inclusion of a patient partner as a co-moderator will ensure that lived experiences and challenges are integrated into the conversation, making the session accessible to a diverse audience. By the end of the session, attendees will have a deeper understanding of the complexities of cognitive dysfunction in rheumatic diseases, equipping them with knowledge to empower patient care and self-management.
Speaker: Mary Alore, MBA – Self-employed
Speaker: Daniel Whibley, PhD – University of Michigan
Speaker: Patti Katz, PhD – UCSF
Speaker: Yen Chen, PhD, MS, BS (she/her/hers) – University of Michigan